Explore All Access
Check if your research matches the topics covered in Current Pharmaceutical Design?
- Degree of match
- Common matching concepts
- Additional journal recommendations
Current Pharmaceutical Design : Impact Factor & More
eISSN: 1873-4286pISSN: 1381-6128
Share this on:
Check your submission readiness
Find out how your manuscript stacks up against 24 technical compliance and 6 language quality checks.
Aims and Scope
Current Pharmaceutical Design is a peer-reviewed medical journal which covers issues related to pharmacology and medicinal chemistry. Each issue is devoted to a single major therapeutic area. For each issue, an executive editor is chosen who is an acknowledged authority in that field. Less
Current Pharmaceutical Design Key Metrics
CiteScore 
5.8
H-Index
176
Impact Factor
< 5
SJR
Q2Pharmacology
SNIP
0.73
Topics Covered on Current Pharmaceutical Design
Disease
Oxidative stress
Curcumin
Drug delivery
Inflammation
Multiple sclerosis
Chemical structure
Heart failure
Treatment options
Anti-inflammatory
Type 2 diabetes
Blood pressure
Cancer development
Breast cancer
Machine learning
Nanomaterials
Liver disease
Reactive oxygen species
Central nervous system
Heart disease
Current Pharmaceutical Design Journal Specifications
Indexed in the following public directories
Web of Science 
Scopus 
SJR
| Overview | |
| Publisher | BENTHAM SCIENCE PUBL LTD |
| Language | English |
| Frequency | Weekly |
| General Details | |
| Language | English |
| Frequency | Weekly |
| Publication Start Year | 1995 |
| Publisher URL | Visit website |
| Website URL | Visit website |
View less
Planning to publish in Current Pharmaceutical Design ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers in Current Pharmaceutical Design
Biocompatible Electrospun Hydrogel Fibers for Advanced Wound Healing Therapies.
- 1 Dec 2024
- Current pharmaceutical design
Sesamol Loaded Silver Nanoparticles Gel Engineered for Wound Healing via Topical Delivery: Optimization In vitro and Ex vivo Evaluation.
- 1 Dec 2024
- Current pharmaceutical design
Preparation and Characterization of Nanostructured Lipid Carriers (NLCs) Containing Glycyrrhiza glabra Extract for the Treatment of Skin Hyperpigmentation.
- 1 Dec 2024
- Current pharmaceutical design
Synthesis of Chalcones, Screening In silico and In vitro and Evaluation of Helicobacter pylori Adhesion by Molecular Docking.
- 1 Dec 2024
- Current pharmaceutical design
The Influence of Antidiabetic Medications on Diagnostic Accuracy of Plasma Tau 217 Assay.
- 1 Dec 2024
- Current pharmaceutical design
Experiments Validated the Development of Zebrafish Embryos and Toxicological Mechanism of Borneols in Perinatal Period.
- 1 Dec 2024
- Current pharmaceutical design
Biocompatible Electrospun Hydrogel Fibers for Advanced Wound Healing Therapies.
- 1 Dec 2024
- Current pharmaceutical design
Sesamol Loaded Silver Nanoparticles Gel Engineered for Wound Healing via Topical Delivery: Optimization In vitro and Ex vivo Evaluation.
- 1 Dec 2024
- Current pharmaceutical design
Preparation and Characterization of Nanostructured Lipid Carriers (NLCs) Containing Glycyrrhiza glabra Extract for the Treatment of Skin Hyperpigmentation.
- 1 Dec 2024
- Current pharmaceutical design
Synthesis of Chalcones, Screening In silico and In vitro and Evaluation of Helicobacter pylori Adhesion by Molecular Docking.
- 1 Dec 2024
- Current pharmaceutical design
The Influence of Antidiabetic Medications on Diagnostic Accuracy of Plasma Tau 217 Assay.
- 1 Dec 2024
- Current pharmaceutical design
Experiments Validated the Development of Zebrafish Embryos and Toxicological Mechanism of Borneols in Perinatal Period.
- 1 Dec 2024
- Current pharmaceutical design
Compare Similar Journals with Current Pharmaceutical Design
Select Journals to Compare with Current Pharmaceutical Design
Total journals - 9
You can select up to 3 Journals at a time
International Journal of Molecular Sciences
Publisher: MDPI
Scientific Reports
Publisher: NATURE PORTFOLIO
Frontiers in Pharmacology
Publisher: FRONTIERS MEDIA SA
Biomedicine and Pharmacotherapy
Publisher: ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER
PLoS ONE
Publisher: PUBLIC LIBRARY SCIENCE
Molecules
Publisher: MDPI
Nutrients
Publisher: MDPI
Journal of Clinical Medicine
Publisher: MDPI
Pharmacological Research
Publisher: ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD
0 Journals Selected to compare with
Current Pharmaceutical Design
Compare journals across 7 parameters SJR Ranking, Topics covered, Indexing Database, Publication Review Time, Publication Type, Article Processing Charges & Recently Published papers
SJR Ranking, Topics covered, Indexing Database, Publication Review Time, Publication Type, Article Processing Charges & Recently Published papers
Get detailed Journal comparison report on your email by signing up
FAQs on Current Pharmaceutical Design
How long has Current Pharmaceutical Design been actively publishing? 
Current Pharmaceutical Design has been in operation since 1995 till date.
What is the publishing frequency of Current Pharmaceutical Design?
Current Pharmaceutical Design published with a Weekly frequency.
How many articles did Current Pharmaceutical Design publish last year?
In 2023, Current Pharmaceutical Design publsihed 322 articles.
What is the eISSN & pISSN for Current Pharmaceutical Design?
For Current Pharmaceutical Design, eISSN is 1873-4286 and pISSN is 1381-6128.
What is Citescore for Current Pharmaceutical Design?
Citescore for Current Pharmaceutical Design is 5.8.
What is the H Index for Current Pharmaceutical Design ?
H Index for Current Pharmaceutical Design is 176.
What is SNIP score for Current Pharmaceutical Design?
SNIP score for Current Pharmaceutical Design is 0.73.
What is the SJR for Current Pharmaceutical Design?
SJR for Current Pharmaceutical Design is Q2.
Who is the publisher of Current Pharmaceutical Design?
BENTHAM SCIENCE PUBL LTD is the publisher of Current Pharmaceutical Design.
